The Lancet OncologyVolume 19, Issue 10, October 2018, Page e513NewsNew ESMO scale ranks mutations as cancer medicine targetsAuthor links open overlay panelJanet FrickerShow moreShareCitehttps://doi.org/10.1016/S1470-2045(18)30664-8Get rights and contentRecommended articlesReferences (0)Cited by (0)View full text© 2018 Elsevier Ltd. All rights reserved.